Mergers & Acquisitions - Licensing, Respiratory and Pulmonary


Popular Filters

Grifols gains global rights to Aradigm's Pulmaquin


Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

MedicinesCo takes equity stake in GeNO, gaining access to nitric oxide platforms


USA-based The Medicines Company (Nasdaq: MDCO) says it has acquired a non-controlling equity investment…

GeNOLicensingMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryThe Medicines Company

Back to top